How much funding has Ribbon Biolabs raised?

Ribbon Biolabs has raised $20.1M in total funding, most recently a Series A round.

What industry is Ribbon Biolabs in?

Ribbon Biolabs operates in Biotech.

How many employees does Ribbon Biolabs have?

Ribbon Biolabs has 11-50 employees.

Ribbon Biolabs

Q: Who are Ribbon Biolabs's investors?

Ribbon Biolabs's investors include Hadean Ventures, Lansdowne Partners, Helicase Venture.

Making The Impossible Possible

Biotech

Employees: 11–50
Business Model: B2B
Website: ribbonbio.com

Total Funding: $20.1M
Last Round: $20.1M Series AJan 2022
Rounds: 2

About

Ribbon Bio is a Vienna-based synthetic biology company that produces MiroSynth™ DNA using proprietary algorithm-driven enzymatic synthesis technology. Its platform manufactures pristine, high-accuracy synthetic DNA molecules — both linear (up to 12 kb) and circular (up to 20 kb) — free of bacterial constraints, enabling next-generation mRNA, CAR-T, and gene therapy applications. Ribbon serves biopharma and synthetic biology partners worldwide.

Summary

Ribbon Biolabs is a Biotech company. It has raised $20.1M in total across 2 rounds, most recently a $20.1M Series A round in Jan 2022. Investors include Hadean Ventures, Lansdowne Partners and Helicase Venture.